Sat, Sep 20, 2014, 6:38 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • dctrig dctrig Mar 14, 2013 3:16 PM Flag

    FDA Just Gifted Cytokinetics

    Just plug in "ALS" for "Alzheimer's" in below news piece:
    Just weeks after pointing R&D groups engaged in Alzheimer's drug research to early-stage patients, the FDA is proposing to lower the bar biotechs will have to clear in order to gain an approval. And faced with a string of blockbuster collapses in Phase III, regulators are signaling a greater willingness to offer early, accelerated approvals for the most promising therapies that come out of the pipeline.
    cognitive improvements alone or preventive measures proven with biomarkers.

    These new standards--initially addressed in a new draft guidance last month--could radically alter the R&D landscape for Alzheimer's drugs, widely perceived as a golden ticket to instant blockbuster status. They could also open a pathway to new therapies that could help millions of patients grapple with a mysterious and terrible disease.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.14+0.28(+7.25%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.